scispace - formally typeset
P

Peter Arner

Researcher at Karolinska Institutet

Publications -  565
Citations -  56932

Peter Arner is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Adipose tissue & Lipolysis. The author has an hindex of 114, co-authored 553 publications receiving 52710 citations. Previous affiliations of Peter Arner include Karolinska University Hospital & Bristol-Myers Squibb.

Papers
More filters
Journal ArticleDOI

Role of Follistatin in Promoting Adipogenesis in Women

TL;DR: Down-regulated WAT expression of follistatin in obesity may counteract adiposity but could, by inhibiting adipogenesis, contribute to hypertrophic obesity (large fat cells) and insulin resistance.
Journal ArticleDOI

Long-term Protective Changes in Adipose Tissue After Gastric Bypass

TL;DR: RYGB improves long-term insulin sensitivity and adipose phenotypes beyond the control state despite weight regain and postoperative beneficial alterations in adipose function may be involved in the diabetes-protective effect of bariatric surgery.
Journal ArticleDOI

The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins.

TL;DR: The Q/E27 polymorphism in the β2‐adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride‐rich lipoproteins.
Journal ArticleDOI

Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.

TL;DR: It is concluded that 3 months of treatment with testosterone undecanoate in postmenopausal women induces insulin resistance and an adverse serum lipid profile but may increase lean body mass.
Journal ArticleDOI

Pancreatic beta-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase.

TL;DR: It is proposed that hormone-sensitive lipase is involved in mediating beta-cell lipotoxicity by providing ligands for peroxisome proliferator-activated receptors and other lipid-activated transcription factors, which in turn alter the expression of critical genes.